Development and Use of a Work-related Quality of Life Instrument

• Research type

  Research Study

• Full title

  Medical Affairs Pharmaceutical Physician Work-related Quality of Life (MAPPWrQoL) Instrument Development and Patient Registry (MAPPWrQoLReg).

• IRAS ID

  303867

• Contact name

  Omolade Femi-Ajao

• Contact email

  research@medialis.co.uk

• Sponsor organisation

  Medialis Ltd

• Duration of Study in the UK

  3 years, 0 months, 14 days

• Research summary

  Occupational burn-out and work-based stress have been identified as an issue of significance, affecting the physical, mental and emotional health of affected patients, thereby impacting their quality of life (QoL). Although there are generic questionnaires for capturing the impact of the work environment on stress, there are limited occupation-specific tools. Specifically, there are no tools for assessing the effects of occupational burn-out and work-based stress experienced by medical affairs pharmaceutical physicians (MAPP), a specialised group of medical doctors. When experiencing stress, anxiety, and depression due to their work, these specialised groups of medical doctors are likely to use NHS services as patients. Thus, the overarching aim of this project is to create a work-related quality of life instrument, to complement existing tools and ongoing initiatives geared towards improving the quality of life of medical professionals.

  This observational study will recruit patients to contribute to creating a MAPP work-related participant-reported outcome measure on the impact of work-related performance on quality of life. All study contact will be online. The creation of this measure will form Phase 1 of the online surveys to find out their preferences of areas of their work performance to include in such a measure. We intend to recruit 15 patients for this phase. This will involve three online surveys, 1) to ask which areas of life they feel are affected and how; 2) to find consensus about the areas to be included; 3) to weigh the relevance of these areas in relation to each other. The measure will then be used longitudinally with study participants and opened to wider recruitment for capturing their QoL monthly for 12 months. In total, up to 180 patients are expected to be recruited to the study.

• REC name

  London - Riverside Research Ethics Committee

• REC reference

  21/PR/1397

• Date of REC Opinion

  15 Oct 2021

• REC opinion

  Favourable Opinion